HCWB — Hcw Biologics Cashflow Statement
0.000.00%
Last trade - 00:00- $2.45m
- $7.31m
- $0.05m
Annual cashflow statement for Hcw Biologics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.9 | -14.9 | -25 | -30 | -7.96 |
| Depreciation | |||||
| Non-Cash Items | -0.112 | 1.31 | 5.99 | 1.01 | -3.69 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.46 | 2.49 | -4.64 | 13.6 | -2.78 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -11 | -10.4 | -22.5 | -14.2 | -13.4 |
| Capital Expenditures | -0.047 | -10.3 | -6.2 | -0.262 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -35 | 25 | 10 | 0 | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -35 | 14.7 | 3.8 | -0.262 | 0 |
| Financing Cash Flow Items | -6.76 | -0.191 | 0 | -0.638 | -1.21 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 49.3 | 6.27 | -0.015 | 15.6 | 10.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.27 | 10.6 | -18.7 | 1.08 | -2.72 |